Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.
Maharashtra's capital city, Mumbai has made the RT-PCR test mandatory for international passengers arriving from Europe, China, Middle East and few more countries.
EXAMIANS